OBJECTIVES: To determine the effects of obesity on fasting plasma leptin levels and assess the effects of feeding on plasma leptin and OB gene expression in subcutaneous adipose tissue in non-diabetic subjects. DESIGN: Blood and subcutaneous adipose tissue needle biopsy samples were obtained after an overnight fast and 1, 2 and 3 h following a mixed meal (606 kcal). SUBJECTS: Eighteen female subjects: eight lean with a mean age of 40.1 yr (range 20±65) and mean body mass index of 22.24 kg/m 2 (range 18.6±26.6) and ten obese subjects with a mean age of 48.6 yr (range 29±71) and body mass index of 33.53 kg/m 2 (range 28.7±41.7). RESULTS: Apart from obesity the only signi®cant difference between groups was a 2.6 fold higher fasting plasma leptin concentration in obese subjects compared to leans (26.9 AE 2.9 vs 10.2 AE 2.22 (P`0.05) respectively). Adipose tissue OB mRNA levels were not signi®cantly higher in the obese group. Plasma leptin correlated with BMI and visceral fat weight in lean subjects only. No signi®cant association between plasma leptin and adiposity was evident in obese patients. In addition, there was no association between plasma leptin and the insulin:glucose ratio (an index of insulin sensitivity). Following a mixed meal, post-prandial plasma insulin levels were signi®cantly increased, with a concomitant signi®cant reduction in plasma NEFA levels in both groups. Despite the large increase in plasma insulin, there were no post-prandial changes in either plasma leptin concentrations or subcutaneous adipose tissue OB mRNA levels in either lean or obese subjects. CONCLUSIONS: The data indicate that plasma leptin levels are correlated with the degree of adiposity, especially in lean subjects, and con®rm that circulating leptin levels are greater in obese subjects than lean subjects. The present study also failed to show a signi®cant association between plasma leptin and insulin sensitivity in lean and obese women. Furthermore, plasma leptin and subcutaneous adipose tissue OB gene expression are not under short term regulation following feeding in fasted lean or obese female subjects.
Introduction
The mechanisms co-ordinating food intake and energy balance to maintain adipose tissue stores at an optimum level and therefore ideal body weight are incompletely understood. A promising advancement in this area was the discovery of the obesity (OB) gene and its product, leptin, in the ob/ob obese mouse. 1 The OB gene appears to be expressed exclusively in adipose tissue. 1 A mutation in the mouse OB gene in strain C57BL/6J ob/ob converts Arg 105 to a stop codon leading to a truncated, inactive form of leptin. A second OB mutant, found in the co-isogenic mouse strain SM/Ckc Dac ob 2j /ob 2j , does not produce ob mRNA. 1 Both mutations are associated with hyperphagia, reduced energy expenditure and obesity. 1, 2 Thus, in the mouse at least, leptin may be an important component in the regulation of energy balance.
Shortly after the discovery of OB, the complete sequence of a human adipose cDNA encoding leptin was published. 3 The coding region of human leptin is 84% identical to the mouse sequence but there was no evidence for a premature stop codon, or absence of the gene, in human obesity. 3 The lack of a mutation leading to defective leptin was subsequently con®rmed in later studies using a single-strand conformational polymorphism (SSCP) analysis of the protein coding sequence in obese patients with or without non-insulin dependent diabetes. 4, 5 In the ob/ob mouse and the rat it was demonstrated that leptin concentrations are modulated by feeding and insulin levels 6, 7 but this appears to differ from the situation in man. Leptin concentrations are raised in hyperinsulinaemic obese subjects, and both insulin and leptin concentrations fall during weight loss. 8 However, leptin concentrations were not altered following feeding 9 or short-term hyperinsulinaemia. 10 These studies suggest that although long-term hyperinsulinaemia appears to in¯uence basal leptin concentrations, post-prandial rises in insulin or acute insulin infusion do not participate in short-term regulation of leptin.
In the present report we have investigated the effects of obesity on plasma leptin concentration and expression of the OB gene in abdominal subcutaneous adipose tissue in female subjects. In addition we also studied the effects of acute physiological hyperinsulinaemia, induced by consumption of a mixed meal, on plasma leptin and OB gene expression.
Methods
Eight lean (BMI`27 kg/m 2 ) and 10 obese (BMI`28 kg/m 2 ) female volunteers were recruited into the study. Apart from obesity all subjects were in good health (normal clinical chemistry, haematology and ECG). Subjects with overt non-insulin dependent diabetes mellitus (NIDDM) were excluded. Informed written consent was obtained and the study protocol reviewed and approved by the Tayside Committee on Medical Research Ethics.
Study design
Subjects attended the study centre after an overnight fast (no food after 10.00 pm). Blood samples (10 ml) were taken from an antecubital vein. Subcutaneous adipose tissue needle biopsy samples (20±50 mg) were removed from the abdominal region and immediately frozen in liquid nitrogen. Local anaesthetic was used at the biopsy site and all adipose samples were removed from the single needle entry point by rotating the needle 15 C between samples. Samples of blood and adipose tissue were taken before and 1, 2 and 3 h after a mixed meal. The mixed meal consisted of 500 mls of ordinary full cream milk with two sachets of vanilla Build-up (Nestle Â) to provide: energy 606 kcal (2.5 mJ); protein 100 kcal; fat 134 kcal; carbohydrate 372 kcal. All samples were stored at 770 C until assay
Estimation of obesity and insulin sensitivity Body fat was measured by impedance analysis (Holtain Impedance Analyser) and calculated using the equations given by Segal et al. 11 Visceral fat was measured by sagittal diameter of the abdomen in the supine position at the level of lumbar vertebrae 4/5 using callipers manufactured by Holtain and calculated according to Kvist et al. 12 An index of insulin resistance was obtained from the fasting insulin:glucose ratio. 13 
Radioimmunoassay for leptin and insulin
Leptin and insulin concentrations were determined by radioimmunoassay, using commercially available kits (Linco Research, Inc.). In these kits, antibodies were raised against highly puri®ed human leptin and insulin. Both standards and tracers were prepared with human leptin and insulin respectively. Assay procedures followed the detailed instructions supplied with each kit.
Measurement of plasma lipids
Determination of serum glucose, triglyceride and total cholesterol levels were carried out on the CibaCorning 550 Express Clinical Chemistry Analyser in conjunction with commercially available kits produced by Ciba-Corning Diagnostics Corp.. Determination of non-esteri®ed fatty acid (NEFA) levels was carried out on the Ciba-Corning 550 Express Clinical Chemistry Analyser in conjunction with the commercially available NEFA-C kit (Wako Chemicals GmbH) following the detailed manufacturers instructions.
Determination of serum glycerol levels as carried out on the Technicon RA-XT analyser in conjunction with a commercially available kit (Randox Laboratories Ltd.) following the manufacturers instruction.
Slot blot analysis
Total RNA was extracted from each biopsy sample using a solid-phase spin column procedure according to the manufacturers instructions (RNeasy TM ; Qiagen, Dorking, UK).
RNA (200 ng) was denatured in deionized formamide (51% v/v), formaldehyde (6.6%) and 1X SSC at 68 C for 30 min then placed on ice. Two volumes of chilled 20X SSC were added and the samples loaded directly on to a positively charged nylon membrane (Boehringer Mannheim, Lewes, UK) using a slot blot manifold (Stratagene Ltd., Cambridge, UK). The slots were then¯ushed twice with 10X SSC. RNA was ®xed onto the damp membrane by UV cross-linking using a Spectrolinker XL-1500 UV Crosslinker (Spectronics Corporation, New York, USA).
Prehybridization was performed at 45 C for 1.5 h in a modi®ed Church buffer consisting of SDS (7% w/v), deionized formamide (50% v/v), blocking solution (2% v/v; Boehringer Mannheim), 5X SSC, 50 mM sodium phosphate (pH 7.0), 0.1% (w/v) N-lauroylsarcosine, 50 mg/ml yeast tRNA (Sigma, Poole, UK). Hybridization was at 45 C in the prehybridization buffer with the addition of a (DIG)-labeled leptin cDNA probe, made up to 190 ml with DEPC-water, placed in a boiling water bath for 5 min and then chilled on ice. The probe solution was added directly to the modi®ed Church buffer and the membrane was incubated in this solution for 15 h at 45 C. Posthybridization washes and immunological detection of the DIG-labeled probe were performed essentially according to Trayhurn et al.
14 with the exception of the chemiluminescent substrate which was CDP-star (250 mM, Tropix; Cambridge Bioscience, Cambridge, UK). The blot was stripped of hybridized probe with the following procedure: DEPC-water for 5 min; boiled SDS (0.1% w/v) for 10 min; 1X Washing Buffer (Boehringer Mannheim) for 5 min. The immunological detection procedure was repeated and the membrane exposed to ®lm to con®rm that the probe had been removed. The stripping procedure was then repeated, followed by two 5 min washes in 2X SSC. The membrane was next incubated in fresh modi®ed Church buffer as above for 1.5 h at 45 C and re-hybridized with heat-denatured DIG-labelled b-actin cDNA. Washes and detection steps were performed as before. All incubations were performed at room temperature unless otherwise stated. Probes were labelled through incorporation of DIG-11-dUTP (PCR DIG labeling mix, Boehringer Mannheim) by PCR and quantitated by measuring the optical density at 260 nm. On northern analysis the leptin and b-actin probes produced single bands at approximately 4.3 and 1.5 kb respectively (data not shown). Hybridization signals on ®lm were quantitated using a Scanmaster 3 densitometer (Howtek, Hudson, NH, USA) and Whole Band Analyser software (Bio Image, Michigan, USA).
Statistics
Comparison of between group means (lean vs. obese) was performed by one-way analysis of variance (ANOVA). A Tukey's studentized range test was employed to control for the experimental error rate when comparing basal (fasted) with post-prandial values for plasma insulin, plasma NEFA, plasma leptin and subcutaneous adipose tissue OB mRNA. Where there was strong evidence of non-normality, using a normal probability test, Mann Whitney U-test was performed. The relationship between plasma leptin levels and BMI, visceral fat content and glucose/insulin ratio was determined by linear regression analysis. All statistical analysis was performed using SAS Research Scientist Application program, version 1.4 (SAS Institute Inc., Carey, USA).
Results
Blood and adipose tissue samples were obtained from 8 lean and 10 obese female subjects after an overnight fast (baseline) and following a mixed meal.
Fasting plasma insulin concentrations were about 2 fold higher in obese subjects compared to lean but because of the variability of the hyperinsulinaemia in the obese group the difference was not statistically signi®cant ( Table 1 ). The only difference between groups was a signi®cantly (P`0.05) higher circulating leptin concentration in obese subjects (Table 1) . Subcutaneous adipose tissue OB mRNA levels were not signi®cantly different between groups ( Table 2) .
Correlation of plasma leptin with obesity and insulin sensitivity
Fasting plasma leptin concentrations correlated positively with BMI and visceral fat weight as judged by r 2 values with signi®cant ®t to the regression model ( Figure 1 ; Table 3 ). When analysed separately, the correlation between plasma leptin concentrations with BMI or visceral fat weight was stronger for the lean group than for the obese group (Table 3) . Thus, in the obese, non-NIDDM subjects leptin levels appeared to be independent of the degree of adiposity. It must be Table 3 .
remembered however that there are inherent errors in the estimation of visceral fat. Conversely, fasting leptin concentrations in the lean group did appear to be related to the degree of adiposity. When plasma leptin levels were related to the insulin : glucose ratio, no association was found either overall (lean obese) or within individual groups ( Table 3 ). The association appeared to strengthen when the lean group was analysed alone but failed to reach statistical signi®cance (P 0.065).
No signi®cant associations between fasting plasma leptin and NEFA, total cholesterol, triglyceride or glycerol levels were observed (Table 3) . When analysed separately the association between fasting plasma leptin and NEFA (P 0.089) and glycerol (P 0.071) appeared to strengthen when the lean group was analysed separately despite the limited group size (Table 3) .
Effect of feeding on plasma leptin and subcutaneous adipose OB mRNA levels Plasma insulin concentrations were signi®cantly raised 1 h following a 606 kcal mixed meal in both lean and obese subjects. Thereafter, insulin returned to baseline by 2 h (Figure 2 ). The rise in plasma insulin was accompanied by a decline in plasma NEFA in both groups at 1 h with the effect persisting at the 3 h post-prandial measurement (Figure 2) .
In spite of the marked elevation in insulin and concomitant fall in plasma NEFA, plasma leptin and subcutaneous adipose OB mRNA levels were unchanged by refeeding (Figure 2) .
Discussion
In the present study we examined the effect of obesity per se on plasma leptin concentration and expression of the OB gene in subcutaneous adipose tissue in female, non-NIDDM subjects. In addition we also investigated the effects of physiological hyperinsulinaemia on plasma leptin concentration and OB gene expression produced by feeding a mixed 606 kcal mixed meal to fasted subjects. Since completion of this study other reports have appeared, 8 ,10 using similar study designs, to examine the acute regulation of OB gene expression and plasma leptin concentrations. The results of the present study in a limited number of subjects has served to con®rm many of the ®ndings in these reports but a number of differences that extend the current knowledge were noted. Although fasting plasma leptin levels were 2.6 fold higher in the obese subjects compared to leans, OB mRNA levels in abdominal subcutaneous adipose tissue were not signi®cantly different. This is in contrast to studies where an increase in absolute OB mRNA expression in obese subjects was reported 8, 15 and may simply re¯ect differences in the subject entry criteria for these studies. It could also be argued that the increased plasma leptin concentration with no difference in mRNA between lean and obese subjects re¯ects an increased fat cell mass and therefore leptin secretory potential in the obese subjects. In agreement with recent reports, 4, 8, 16 fasting plasma leptin concentrations were found to correlate with indices of adiposity (BMI and visceral fat weight) and, despite the limited number of subjects and the inherent errors in the measurements used, the correlation was highly signi®cant (Table 3) . This association was strengthened by a lack of correlation with lean body mass. However, in contrast to others 15 we found in our analysis that the correlation was primarily due to the lean group, with no association in the obese group when this was analysed separately.
Considine et al 8 reported that where plasma leptin concentrations were raised in obese NIDDM patients, a weight loss programme resulted in a reduction in plasma leptin concentrations paralleling weight loss and reduced hyperinsulinaemia and serum triglycerides. The data were used to postulate that insulin could be a long term regulator of leptin homeostasis in these subjects. However, in non-NIDDM females we could not detect a relationship between fasting plasma leptin levels and plasma insulin, plasma glucose or an insulin sensitivity index (insulin : glucose ratio 13 ) in either lean or obese subjects. This may simply be a consequence of the limited group sizes used in the present study; nevertheless the correlation coef®cients were low and it is possible that insulin becomes in¯uential only in the hyperinsulinaemic state in the presence of hyperglycaemia and not at normal physiological levels.
We also analysed for possible relationships between leptin and plasma lipid concentrations. However, a direct relationship between fasting plasma leptin and plasma cholesterol, triglycerides, glycerol and NEFA was not detected. Interestingly, weak but non signi®-cant, relationships between fasting plasma leptin and NEFA and glycerol were observed. Further studies in a larger cohort of lean non-NIDDM subjects would be required to ascertain whether a relationship between leptin and plasma lipids exists.
The lack of effect of intake of a mixed meal in fasted subjects on plasma leptin and OB gene expression up to 3 h is consistent with a recent report. 8 Thus, despite demonstrating the expected physiological response to feeding, namely an acute hyperinsulinaemia with a concomitant reduction in plasma NEFA, short term postprandial changes in insulin (and indeed other secreted regulators following feeding such as GLP-1) do not acutely regulate OB gene expression or leptin secretion.
Data from the present study have con®rmed and extended previous studies showing that plasma leptin concentrations are raised in obesity and appear to be independent of NIDDM or insulin resistance. We have also demonstrated that plasma leptin concentrations correlated with measures of adiposity and this relationship is upheld in lean but not obese female subjects indicating that perturbations in leptin control may be caused by factors associated with obesity per se. Finally, the data con®rm that leptin is not under short term (`3 h) regulatory control by acute hyperinsulinaemia following feeding.
